Background and Purpose-It is still unclear that impaired cerebrovascular reactivity (CVR) to acetazolamide is comparable to elevated oxygen extraction fraction (OEF) on positron emission tomography (PET) in patients with occlusive carotid diseases. Therefore, in this study, the authors aimed to clarify whether OEF is elevated in all patients with reduced cerebral blood flow (CBF) and CVR (type 3) on single photon emission computed tomography (SPECT), and, if not, to specify the underlying pathophysiology of type 3 but normal OEF.
T here is increasing evidence that hemodynamically compromised patients with internal carotid artery (ICA) occlusion are at higher risk for subsequent ischemic stroke. Over these 20 years, an elevated oxygen extraction fraction (OEF) determined by positron emission tomography (PET) has been believed to represent critical reduction of cerebral perfusion pressure, named as "misery perfusion" or "stage II." 1, 2 Recent statistical analyses have proven that an elevated OEF can be an independent risk factor for subsequent ischemic stroke in patients with occlusive carotid artery disease. [3] [4] [5] Alternatively, cerebrovascular reactivity (CVR) to CO 2 or acetazolamide has also been used to assess cerebral perfusion reserve in patients with occlusive carotid diseases because single photon emission computed tomography (SPECT) or cold xenon computed tomography (CT) is more widely available and can be done at lower costs than PET. Recent studies have proven that quantitative measurements of cerebral blood flow (CBF) and CVR can also be a predictor for subsequent ischemic stroke in patients with ICA or middle cerebral artery (MCA) occlusion. Thus, Kuroda et al (2001) reported that relative risk conferred by reduced CBF and CVR (type 3) was 8.0 (95% CI, 1.9 to 34.4) for ipsilateral stroke. 6 Subsequently, Ogasawara et al also reported similar results. 7 Based on these observations, SPECT has been expected to identify misery perfusion or stage II more easily than PET if CVR is comparable to OEF. 8 However, it is still controversial whether impaired CVR is directly linked to OEF elevation in patients with occlusive carotid artery diseases or not. Thus, previous studies have reported a significant correlation between OEF and CVR to acetazolamide or CO 2 . 9 -14 However, the number of patients included in these studies was not so large, and their hemodynamic and metabolic parameters varied widely among the subjects. On the other hand, recent study has shown that Ϸ40% of patients with reduced CVR have normal OEF when both parameters are evaluated in each patient. 15 The issue is quite important because there may be a significant difference in sensitivity for detecting the patients at higher risk for subsequent stroke between CVR and OEF.
On the other hand, 11 C-flumazenil (FMZ) PET has been accepted as a noninvasive, variable tool to investigate neuronal integrity because FMZ is a specific ligand to the central type of benzodiazepine receptors that are exclusively localized in the neurons. Recent studies have shown that 11 C-FMZ PET can detect ischemia-induced selective neuronal necrosis that is not visible on either CT or MRI. 16, 17 Therefore, in this study, the authors aimed to clarify whether OEF is elevated in all patients who are diagnosed as type 3 on SPECT, and, if not, to specify the underlying pathophysiology of normal OEF in spite of type 3. For this purpose, the authors measured the parameters for oxygen metabolism and for neuronal integrity in type 3 patients with occlusive, using 15 O-gas and 11 C-FMZ PET, respectively.
Subjects and Methods

Patients
The present study included a total of 46 patients who were admitted to our hospital between January 1999 and December 2004. All of them met the following criteria: (1) 25 . The other 3 patients were asymptomatic. Digital subtraction angiography showed ICA occlusion in 27 patients, ICA severe stenosis in 8, MCA occlusion in 5, and MCA severe stenosis in 6. All studies were performed Ն4 weeks after the last ischemic episode because the studies in an earlier period might affect the correct interpretation of the data. 18 
SPECT Measurements
All patients were scanned with a triple-head ␥ camera (GCA-9300/DI; Toshiba) to determine CBF and CVR to acetazolamide, as described previously. 16 Briefly, quantitative blood flow was determined by using the 123 I-IMP injection and single-scan autoradiographic technique. CBF was quantitatively measured before and 15 minutes after intravenous injection of 10 mg/kg acetazolamide on the separate days with an interval of 2 to 3 days. To evaluate cerebral hemodynamics, 10-mm diameter circular regions of interest (ROIs) were symmetrically placed in the ipsilateral and contralateral MCA territories. As described previously, 6, 18, 19 CVR to acetazolamide was quantitatively calculated as: CVR (%)ϭ100ϫ(CBF ACZ ϪCBF rest )/CBF rest , where CBF rest and CBF ACZ represent CBF before and after intravenous injection of acetazolamide, respectively. Normal control values of CBF (meanϮSDϭ38.1Ϯ5.4 mL/min per 100 g) and CVR (30.0Ϯ8.0%) in the MCA territory were obtained from 10 normal volunteers free of cerebrovascular disease. The values were rated as reduced when any of them were less than meanϪ2 SD. Thus, in the current study, patients were judged as type 3 when CBF was Ͻ27 mL/min per 100 g and CVR was Ͻ14%. 16 
PET Measurements
All patients were scanned with ECAT EXACT HRϩ (Siemens) as described previously. 16 The intervals between SPECT and PET measurements were within 2 weeks. One-minute inhalation of 15 O-CO (2 GBq/min) followed by 3-minute static scanning and 3-time arterial blood sampling were performed to measure cerebral blood volume (CBV). After 15-minute inhalation of 15 O-O 2 (0.5 GBq/min), a steady-state O 2 image was scanned and 3-time arterial blood sampling was performed for 5 minutes to measure OEF and cerebral metabolic rate for oxygen (CMRO 2 ). Finally, to determine CBF, steady-state CO 2 image was scanned and 3-time arterial blood sampling was performed for 5 minutes after 15-minute inhalation of 15 O-CO 2 (0.5 GBq/min). Normal PET values were obtained from 10 volunteers: CBF, 44Ϯ4 mL/min per 100 g; CMRO 2 , 3.3Ϯ0.6 mL/min per 100 g; CBV, 3.7Ϯ0.7 mL/min, and OEF, 0.43Ϯ0.05 (meanϮSD). Each PET parameter was obtained using 10-mm diameter circular ROIs. The values were rated as decreased when any of them were less than meanϪ2 SD and rated as increased when any of them were more than meanϩ2 SD.
The dynamic FMZ PET was studied in 19 of 46 patients at the same time that 15 O-gas PET was performed, as reported previously. 16 Briefly, the injected dose of 11 C-FMZ was 370 MBq for each patient. The binding potential (BP) images were calculated pixel by pixel using the reference tissue model. 20 
Data Analysis
To evaluate various parameters obtained from 123 I-IMP SPECT, 15 O-gas PET, and 11 C-FMZ PET, the SPECT and PET images were automatically coregistered to axial T1-weighted MRI images. The SPECT, PET, and MRI images were registered using fully automatic multimodality image registration algorithm on Unix-based workstation (Indigo 2; SGI Inc.). 21 All data were expressed as meanϮSD. The data between 2 groups were compared by use of 2 test or paired t test as appropriate. Differences with a P value of Ͻ0.05 were considered statistically significant.
Results
O PET Parameters
CBF, CBV, CMRO 2 , and OEF in type 3 patients are shown in the Table. There were significant differences in CBF, CMRO 2 , and OEF between the ipsilateral and contralateral MCA areas. However, there was no significant difference in CBV between them.
Relationships between OEF and other PET parameters were analyzed in the ipsilateral hemispheres (Figure 1) Then the values of OEF, CMRO 2 , and CBV were evaluated in each patient. Although OEF was significantly higher in the ipsilateral MCA area than in the contralateral side, OEF was significantly elevated in only 20 (43.5%) of 46 patients. OEF was kept within normal limits in the other 26 patients (Figure 2) . CMRO 2 was significantly higher in patients with elevated OEF than in those with normal OEF: 2.26Ϯ0.41 and 1.78Ϯ0.42 mL/100 g per minute, respectively (Pϭ0.0002; Figure 3 ). Of 20 patients with elevated OEF, 14 (70%) had normal CMRO 2 and the other 6 (30%) had decreased CMRO 2 (Ͻ2.1 mL/100 g per minute). On the other hand, of 26 patients with normal OEF, 7 (26.9%) had normal CMRO 2 and the other 19 (73.1%) had decreased CMRO 2 . Thus, normal CMRO 2 was more frequently observed in patients with elevated OEF than in those with normal OEF (Pϭ0.0032; Figure 3 ).
There was no significant difference in CBV between patients with elevated OEF and with normal OEF: 4.4Ϯ1.1 and 4.0Ϯ1.1 mL/100 g, respectively (Pϭ0.2357; Figure 3 ). However, of 20 patients with elevated OEF, 9 (45%) had increased CBV. Of 26 patients with normal OEF, only 4 (15.4%) had increased CBV. As the result, increased CBV was more frequently denoted in patients with elevated OEF than in those with normal OEF (Pϭ0.0264; Figure 3 ).
C-FMZ Binding Potential
To evaluate the neuronal integrity in patients with type 3 ischemia, 11 C-FMZ PET was performed in 19 (41.3%) of 46 patients. The relationships between the ratio of the ipsilateral to contralateral 11 C-FMZ BP and metabolic parameters were analyzed. There was a significant, positive correlation between the ratio and OEF (R 2 ϭ0.507; Pϭ0.0006; Figure 4 ). The ratio also significantly correlated with CMRO 2 (R 2 ϭ 0.324; Pϭ0.011).
MRI
Using T2-weighted MRI, the localization of cerebral infarction was evaluated to clarify its effects on cerebral oxygen metabolism and neuronal integrity. Subcortical infarction in the ipsilateral hemisphere was found in 7 of 20 patients with elevated OEF and in 16 of 26 patients with normal OEF. There was no significant effect of subcortical infarction on OEF value in type 3 patients ( 2 test Pϭ0.0743).
Discussion
The present results revealed that hemodynamic and metabolic parameters in type 3 patients are not uniform, and that they 
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can be largely classified into 2 subgroups according to OEF value. OEF was significantly elevated in Ϸ40% of type 3 patients and was within normal limits in the others, indicating that type 3 is not always identical to misery perfusion or stage II. CMRO 2 was significantly higher in patients with elevated OEF than in those with normal OEF ( Figure 3A ) and significantly correlated with OEF ( Figure 1D ). Therefore, OEF may depend on the metabolic demand in the ischemic tissue.
As the next step, 11 C-FMZ BP and the localization of cerebral infarction were evaluated to specify the underlying pathophysiology of CMRO 2 reduction in the area with type 3 but normal OEF. Subcortical infarction in the ipsilateral hemisphere was not directly related to type 3 but normal OEF, although previous reports suggested its involvement. 15 However, there was a significant correlation between OEF and the 11 C-FMZ BP in type 3 patients. Because ␥-aminobutyric acid receptors are abundant in the cortex and sensitive to ischemic damage, the specific ligand to their subunits, the central type of benzodiazepine receptors, has been used as a marker of preserved morphological integrity. Garcia et al emphasized the importance of selective neuronal necrosis (incomplete infarction) in human stroke as a pathologic entity. 17 Recently, the authors demonstrated that CMRO 2 and 11 C-FMZ BP were reduced to Ϸ80% of the contralateral side, but there was no significant side-to-side difference in CBV and OEF in patients with reduced CBF and normal CVR (type 4) and concluded that type 4 represents oxygen hypometabolism attributable to ischemia-related selective neuronal damage. 16 Previous studies have shown that the patients with type 4 may not be at high risk for subsequent stroke when medically treated. 6, 18 The PET parameters in patients with type 3 ischemia but normal OEF are quite similar to those in the patients with type 4.
Based on these observations, type 3 may include 2 pathophysiologically different conditions: misery perfusion (or stage II ischemia) attributable to hemodynamic compromise, and matched hypometabolism attributable to incomplete infarction. Although the authors have simply graded cerebral hemodynamics of the patients with occlusive carotid artery diseases into 4 types, type 3 should be subdivided into "true type 3," with elevated OEF, and "type 3.5," with normal OEF, in discussing their pathophysiology and long-term prognosis. It is obscure why CVR is impaired in patients with type 3 but normal OEF. As Yamauchi et al pointed out, such patients may have complex hemodynamic and metabolic changes in response to both reduced perfusion pressure and ischemic tissue damage. 14 Present results mirror previous descriptions, that is, using 133 xenon inhalation method and SPECT, the authors divided 32 patients with ICA occlusion into 4 types and serially measured CBF and CVR after superficial temporal artery to MCA anastomosis. Seven patients were diagnosed as having type 3 before surgery. The CVR normalized in all type 3 patients, suggesting postoperative improvement of cerebral perfusion reserve. But CBF returned to normal range in 3 (42.8%) of 7 type 3 patients. As the result, SPECT parameters altered from type 3 to type 4 in other 4 patients. 18 Furthermore, they recently assessed long-term prognosis of 77 patients who were medically treated because of ICA or MCA occlusion. Of 11 type 3 patients, 4 (36.4%) developed ipsilateral ischemic stroke during follow-up periods. 6 The present results may explain these varieties in type 3 patients.
However, as recent studies have clarified, hemodynamic and metabolic responses to reduced perfusion pressure are not so simple. Patients with "classic" misery perfusion (elevated OEF and CBV) are at highest risk for subsequent stroke. 22 However, CBV changes widely vary in patients with occlusive carotid artery disease. This study also showed that CBV widely varied in spite of OEF values. Further studies would clarify the CBV responses to chronic cerebral ischemia more precisely.
This study showed that type 3 is not equal to misery perfusion. However, SPECT and acetazolamide test are still useful modalities because they can simply select the patients at higher risk for subsequent ischemic stroke at lower costs than PET, as described previously. 6, 7 Thus, it is very valuable to establish the methodology to detect misery perfusion more efficiently with the use of SPECT because PET is not widely available. Based on a significant linear correlation between OEF and 11 C-FMZ BP in this study, the authors propose to evaluate whether 123 I-iomazenil (IMZ) SPECT can detect misery perfusion or stage II ischemia in type 3 patients more efficiently.
123 I-IMZ is an alternative benzodiazepine receptor ligand for SPECT and has been reported that a reduction of its binding reflects oxidative hypometabolism caused by neuronal damage in hemodynamically impaired areas in patients with cerebrovascular disease. [23] [24] [25] Therefore, SPECT may be able to identify the patients with misery perfusion by measuring CVR and 123 I-IMZ binding, if the results on 123 I-IMZ SPECT are comparable to those on 11 C-FMZ PET in patients with occlusive carotid artery diseases.
Conclusion
Previous studies have shown that type 3 (reduced CBF and CVR) as well as elevated OEF is statistically independent predictors for subsequent stroke in patients with occlusive carotid artery diseases. 3, 4, 6, 26 However, this study clearly showed that OEF was elevated in Ϸ40% of patients with reduced CBF and CVR (type 3). Significant, positive linear relationships were observed between OEF and CMRO 2 and between OEF and 11 C-FMZ BP. Type 3 may include 2 pathophysiologically different conditions: misery perfusion (or stage II) attributable to hemodynamic compromise and matched hypometabolism attributable to incomplete infarction. Further studies would be necessary to define the SPECT parameter to select the patients at higher risk for subsequent stroke more specifically.
